Sequencing Grade Modified Trypsin, Frozen, 100ug

The University of Virginia awarded contract A207_PO-0478747-V3 to Promega Corporation on October 10, 2026, for the procurement of sequencing-grade modified trypsin in frozen form. The contract calls for delivery of 1,908 units at $1.00 per unit, resulting in a cumulative contract value of $1,908.00. Sequencing-grade modified trypsin is a protease enzyme commonly utilized in molecular biology and proteomics research applications, including protein digestion for mass spectrometry analysis.

The contracting organization, University of Virginia, will serve as the delivery point for the ordered materials. While specific performance periods and annual value breakdowns are not delineated in the available documentation, the contract represents a single-purchase procurement action. Promega Corporation, the awarded prime contractor, is responsible for fulfilling the complete order of trypsin product to the specified destination within the terms established by this contract action.